Although the treatment effectively controlled PTH levels, two significant adverse events were noted as follows: (1) renal cancer - two patients were diagnosed with renal cancer by annual abdominal echography, CT imaging, and hematuria, which was confirmed to be derived from acquired cystic disease of the kidney with unilateral removal of the kidney. This evidence concerns the gene PTH and renal carcinoma.